Antidepressant use in psychiatry and medicine: Importance for dental practice

Journal of the American Dental Association

Volumn 134, Issue 1, 2003, Pages 71-79

  Keene Jr , Joseph J ^a   Galasko, Gail T ^a   Land, Martin F ^a  

^a School of Dental Medicine   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MAPROTILINE; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PHENELZINE; PROTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANYLCYPROMINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE; VASOCONSTRICTOR AGENT; VENLAFAXINE;

ADOLESCENT; ADULT; AGED; ANTICHOLINERGIC EFFECT; ARTICLE; DRUG CLASSIFICATION; DRUG EFFECT; DRUG MECHANISM; DRUG USE; FEMALE; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; ORTHOSTATIC HYPOTENSION; SCHOOL CHILD; SEDATION; SIDE EFFECT; TOOTH DISEASE; TREATMENT OUTCOME; XEROSTOMIA; CHEMICALLY INDUCED DISORDER; CHILD; DENTAL CARE; DRUG INTERACTION; MIDDLE AGED; POLYPHARMACY; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; CHILD; DENTAL CARE FOR CHRONICALLY ILL; DRUG INTERACTIONS; FEMALE; HUMANS; HYPOTENSION, ORTHOSTATIC; MALE; MIDDLE AGED; POLYPHARMACY; RETROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS; VASOCONSTRICTOR AGENTS; XEROSTOMIA;

EID: 0037267028     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2003.0019     Document Type: Article

References (89)

1. Modigh K. Antidepressant drugs in anxiety disorders. Acta Psychiatr Scand Suppl 1987;335(76):57-74.
2. Agosti V, Stewart JW, Quitkin FM. Life satisfaction and psychosocial functioning in chronic depression: effect of acute treatment with antidepressants. J Affect Disord 1991;23(1):35-41.
3. Goldberg JF. New drugs in psychiatry. Emerg Med Clin North Am 2000;18(2):211-31.
4. Schatzberg AF. New indications for antidepressants. J Clin Psychiatry 2000;61(suppl 11):9-17.
5. Wells KB, Stewart A, Hays RD, et al. The functioning and well-being of depressed patients: results from the Medical Outcomes Study. JAMA 1989;262:914-9.
6. Peveler R, Carson A, Rodin G. Depression in medical patients. Br Med J 2002;325:149-52.
7. Godfrey RG. A guide to the understanding and use of tricyclic antidepressants in the overall management of fibromyalgia and other chronic pain syndromes. Arch Intern Med 1996;156:1047-52.
8. O'Malley PG, Balden E, Tomkins G, Santoro J, Kroenke K, Jackson JL. Treatment of fibromyalgia with antidepressants: a meta-analysis. J Gen Intern Med 2000;15:659-66.
9. Mody GM, Meyers OL. Therapeutic requirements in rheumatoid arthritis. S Afr Med J 1990;77:497-9.
10. Rani PU, Naidu MU, Prasad VB, Rao TR, Shobha JC. An evaluation of antidepressants in rheumatic pain conditions. Anesth Analg 1996;83(2):371-5.
11. Fishbain D. Evidence-based data on pain relief with antidepressants. Ann Med 2000;32:305-16.
12. Egbunike IG, Chaffee BJ. Antidepressants in the management of chronic pain syndromes. Pharmacotherapy 1990;10:262-70.
13. Salerno SM, Browning R, Jackson JL. The effect of antidepressant treatment on chronic back pain: a meta-analysis. Arch Intern Med 2002;162(1):19-24.
14. Adelman JU, Adelman RD. Current options for the prevention and treatment of migraine. Clin Ther 2001;23:772-88.
15. Belgrade MJ. Following the clues to neuropathic pain: distribution and other leads reveal the cause and the treatment approach. Postgrad Med 1999;106(6):127-40.
16. Goodnick PJ. Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy. Ann Clin Psychiatry 2001;13(1):31-41.
17. Jensen PG, Larson JR. Management of painful diabetic neuropathy. Drugs Aging 2001;18:737-49.
18. Dionne RA. Antidepressants for chronic orofacial pain. Compend Contin Educ Dent 2000;21:822-4.
19. Vickers ER, Cousins MJ. Neuropathic orofacial pain, Part 2: diagnostic procedures, treatment guidelines and case reports. Aust Endod J 2000;26(2):53-63.
20. Kloeffler GD, Mahan PE. Chronic-pain management: a timely opportunity. J Calif Dent Assoc 2001;29:296-302.
21. Sakulsripong M, Curran HV, Lader M. Does tolerance develop to the sedative and amnesic effects of antidepressants? A comparison of amitriptyline, trazodone and placebo. Eur J Clin Pharmacol 1991;40(1):43-8.
22. Hajak G, Rodenbeck A, Voderholzer U, et al. Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study. J Clin Psychiatry 2001;62:453-63.
23. George TP, Vessicchio JC, Termine A, et al. A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biol Psychiatry 2002;52(1):53-61.
24. Thase ME, Salloum IM, Cornelius JD. Comorbid alcoholism and depression: treatment issues. J Clin Psychiatry 2001;62(suppl 20):32-41.
25. Hamilton SP, Nunes EV, Janal M, Weber L. The effect of sertraline on methadone plasma levels in methadone-maintenance patients. Am J Addict 2000;9(1):63-9.
26. Robinson PH. Review article: recognition and treatment of eating disorders in primary and secondary care. Aliment Pharmacol Ther 2000;14:367-77.
27. Peeters FP, deVries MW, Vissink A. Risks for oral health with the use of antidepressants. Gen Hosp Psychiatry 1998;20(3):150-4.
28. Verhaeverbeke I, Mets T. Drug-induced orthostatic hypotension in the elderly: avoiding its onset. Drug Saf 1997;17(2):105-18.
29. Glassman AH. Cardiovascular effects of antidepressant drugs: updated. Int Clin Psychopharmacol 1998;13(suppl 5):S25-30.
30. Atkinson JC, Fox PC. Salivary gland dysfunction. Clin Geriatr Med 1992;8:499-511.
31. Jensen JL, Barkvoll P. Clinical implications of the dry mouth: oral mucosal diseases. Ann N Y Acad Sci 1998;842:156-62.
32. Astor FC, Hanft KL, Ciocon JO. Xerostomia: a prevalent condition in the elderly. Ear Nose Throat J 1999;78:476-9.
33. Gilbert GH, Heft MW, Duncan RP. Mouth dryness as reported by older Floridians. Community Dent Oral Epidemiol 1993;21:390-7.
34. deVries MW, Peeters F. Dental caries with long-term use of antidepressants. Lancet 1995;346:1640.
35. Greenspan D. Xerostomia: diagnosis and management. Oncology (Huntingt) 1996;10(3 suppl):7-11.
36. Friedlander AH, Mahler ME. Major depressive disorder. Psychopathology, medical management and dental implications. JADA 2001;132:629-38.
37. von Knorring AL, Wahlin YB. Tricyclic antidepressants and dental caries in children. Neuropsychobiology 1986;15(3-4):143-5.
38. Meskin L, Berg R. Impact of older adults on private dental practices, 1988-1998. JADA 2000;131:1188-95.
39. Thomson WM, Slade GD, Spencer AJ. Dental caries experience and use of prescription medications among people aged 60+ in South Australia. Gerodontology 1995;12:104-10.
40. Budtz-Jorgensen E, Chung JP, Rapin CH. Nutrition and oral health. Best Pract Res Clin Gastroenterol 2001;15:885-96.
41. Schoenberger JA. Drug-induced orthostatic hypotension. Drug Saf 1991;6:402-7.
42. Liu BA, Topper AK, Reeves RA, Gryfe C, Maki BE. Falls among older people: relationship to medication use and orthostatic hypotension. J Am Geriatr Soc 1995;43:1141-5.
43. Mets TF. Drug-induced orthostatic hypotension in older patients. Drugs Aging 1995;6(3):219-28.
44. Jackson WK, Roose SP, Glassman AH. Cardiovascular toxicity and tricyclic antidepressants. Biomed Pharmacother 1987;41:377-82.
45. Murray JB. Cardiac disorders and antidepressant medications. J Psychol 2000;134(2):162-8.
46. Chong SA, Mythily, Mahendran R. Cardiac effects of psychotropic drugs. Ann Acad Med Singapore 2001;30:625-31.
47. Perry PJ, Alexander B, Liskow BI. Psychotropic drug handbook. 7th ed. Washington: American Psychiatric Press; 1997:131-220.
48. Rabkin JG, Quitkin F, Harrison W, et al. Adverse reactions to monoamine oxidase inhibitors, part I: a comparative study. J Clin Psychopharmacol 1984;4:270-8.
49. Stahl SM. Neuroendocrine markers of serotonin responsivity in depression. Prog Neuropsychopharmacol Biol Psychiatry 1992;16:655-9.
50. Feighner JP. Mechanism of action of antidepressant medications. J Clin Psychiatry 1999;60(suppl 4):4-11.
51. Coccaro EF, Siever LJ. Second generation antidepressants: a comparative review. J Clin Pharmacol 1985;25:241-60.
52. Lader MH. Tolerability and safety: essentials in antidepressant pharmacotherapy. J Clin Psychiatry 1996;57(suppl 2):39-44.
53. Stahl SM. Basic psychopharmacology of antidepressants, part 1: antidepressants have seven distinct mechanisms of action. J Clin Psychiatry 1998;59(suppl 4):5-14.
54. Antilla SA, Leinonen EV. A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev 2001;7:249-64.
55. Katzung BG. Basic and clinical pharmacology. 8th ed. New York: McGraw-Hill; 2001:498-511.
56. Kastrup EK, Burnham TH, Short RM, Bell WI. Drug facts and comparisons. St. Louis: Facts and comparisons; 2001.
57. Gage TW, Pickett FA. Mosby's dental drug reference. 5th ed. St. Louis: Mosby; 2001.
58. Wynn RL, Meiller TF, Crossley HL. Drug information handbook for dentistry, 1999-2000. 5th ed. Hudson, Ohio: Lexi-Comp; 1999.
59. Hardman JG, Limbird LE, Gilman AG. Goodman & Gilman's the pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill; 2001:447-83.
60. Friedlander AH, Mahler ME. Major depressive disorder: psychopathology, medical management and dental implications. JADA 2001;132:629-38.
61. Egberts AC, Leufkens HG, Hofman A, Hoes AW. Incidence of antidepressant drug use in older adults and association with chronic diseases: the Rotterdam Study. Int Clin Psychopharmacol 1997;12:217-23.
62. Middleton N, Gunnell D, Whitley E, Dorling D, Frankel S. Secular trends in antidepressant prescribing in the UK, 1975-1998. J Public Health Med 2001;23:262-7.
63. Poolsup N, Li Wan Po A, Knight TL. Pharmacogenetics and psychopharmacotherapy. J Clin Pharm Ther 2000;25(3):197-220.
64. Roe CM, McNamara AM, Motheral BR. Gender- and age-related prescription drug use patterns. Ann Pharmacother 2002;36(1):30-9.
65. Roose SP, Spatz E. Treatment of depression in patients with heart disease. J Clin Psychiatry 1999;60(suppl 20):34-7.
66. Gainotti G, Antonucci G, Marra C, Paolucci S. Relation between depression after stroke, antidepressant therapy, and functional recovery. J Neurol Neurosurg Psychiatry 2001;71:258-61.
67. Gottfries CG. Late life depression. Eur Arch Psychiatry Clin Neurosci 2001;251(suppl 2):1157-61.
68. Bukberg J, Penman D, Holland JC. Depression in hospitalized cancer patients. Psychosom Med 1984;46(3):199-212.
69. Angelino AF, Treisman GJ. Major depression and demoralization in cancer patients: diagnostic and treatment considerations. Support Care Cancer 2001;9:344-9.
70. Berney A, Stiefel F, Mazzocato C, Buclin T. Psychopharmacology in supportive care of cancer: a review for the clinician, III: antidepressants. Support Care Cancer 2000;8:278-86.
71. Farrar JT, Portenoy RK. Neuropathic cancer pain: the role of adjuvant analgesics. Oncology (Huntingt) 2001;15:1435-45.
72. Kay J, Bienenfeld D, Slomowitz M, et al. Use of tricyclic antidepressants in recepients of heart transplants. Psychosomatics 1991;32(2):165-70.
73. Strouse TB, Fairbanks LA, Skotzko CE, Fawzy FT. Fluoxetine and cyclosporine in organ transplantation: failure to detect significant drug interactions or adverse clinical events in depressed organ recipients. Psychosomatics 1996;37(1):23-30.
74. Vella JP, Sayegh MH. Interactions between cyclosporine and newer antidepressant medications. Am J Kidney Dis 1998;31(2):320-3.
75. McConville BJ, Steichen-Asch P, Harris R, et al. Pediatric bone marrow transplants: psychological aspects. Can J Psychiatry 1990;35:769-75.
76. Kanner AM, Nieto JC. Depressive disorders in epilepsy. Neurology 1999;53(suppl 2):S26-32.
77. Cummings JL, Masterman DL. Depression in patients with Parkinson's disease. Int J Geriatr Psychiatry 1999;14:711-8.
78. Richard IH. Depression in Parkinson's Disease. Curr Treat Options Neurol 2000;2:263-74.
79. Rodgers J, Bland R. Psychiatric manifestations of multiple sclerosis: a review. Can J Psychiatry 1996;41:441-5.
80. Guay DR. Adjunctive agents in the management of chronic pain. Pharmacotherapy 2001;21:1070-81.
81. Wieling W, Harms MP, Kortz RA, Linzer M. Initial orthostatic hypotension as a cause of recurrent syncope: a case report. Clin Auton Res 2001;11:269-70.
82. Cohen I, Rogers P, Burke V, Beilin LJ. Predicators of medication use, compliance and symptoms of hypotension in a community-based sample of elderly men and women. J Clin Pharm Ther 1998;23:423-32.
83. Verhaeverbeke I, Mets T. Drug-induced orthostatic hypotension in the elderly: avoiding its onset. Drug Saf 1997;17(2):105-18.
84. Thwaites JH. Practical aspects of drug treatment in elderly patients with mobility problems. Drugs Aging 1999;14(2):105-14.
85. Schatzberg AF, Cole JO, DeBattista C. Manual of clinical psychopharmacology. 3rd ed. Washington: American Psychiatric Press; 1997:61.
86. Friedlander AH, West LJ. Dental management of the patient with major depression. Oral Surg Oral Med Oral Pathol 1991;71:573-8.
87. Carlson JE. Assessment of orthostatic blood pressure: measurement technique and clinical applications. South Med J 1999;92(2):167-73.
88. Little JW, Falace DA, Miller CS, Rhodus NL. Dental management of the medically compromised patient. 5th ed. St. Louis: Mosby; 1997:559.
89. Yagiela JA. Adverse drug interactions in dental practice: interactions associated with vasoconstrictors - part V of a series. JADA 1999;130:701-9.